-+ 0.00%
-+ 0.00%
-+ 0.00%

Waldencast's Obagi and Schweiger Dermatology launch ALOHA Phase 4 study of saypha MagIQ injectable

Reuters·02/27/2026 13:33:14

Please log in to view news